$18.79 0.15 (+0.80%)
12/4/2009 10:40 AM

Pfizer, Inc. (PFE)

CAPS Rating: 4 out of 5

A research-based, pharmaceutical Company which discovers, develops, manufactures and markets prescription medicines for humans and animals.

Recs

0
Member Avatar TDRH (99.98) Submitted: 9/29/2008 11:14:20 PM : Outperform Start Price: $17.93 PFE Score: +10.01

Yes the pipleine is dry, yes it was a value trap when I bought it at $23.50, but the 6.9% dividend yield should keep this one from falling further and could preserve capital. Still positive cash flow and AAA rating, does not need to borrow money for operations, still feeding of the cash cows near expiry.

Report this Post 0 Comments

Featured Broker Partners